BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Antengene And Junshi Biosciences Enter Clinical Collaboration To Advance ATG 037 And JS207 Combination In Solid Tumors

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, ...

February 26, 2026 | News

SteinCares And Shilpa Biologicals Sign Strategic Licensing Agreement To Commercialise Biosimilar Across Latin America

New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform Collaborati...

February 26, 2026 | News

Etherna And Almirall Advance LAD116 mRNA LNP Therapy Into IND Enabling Studies For Non Melanoma Skin Cancer

etherna, a leading provider of cutting-edge mRNA and lipid nanoparticle (LNP) technology across the biotech and pharma industry, announces that one o...

February 25, 2026 | News

iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones

The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...

February 25, 2026 | News

Bioxytran Initiates University Of Georgia Collaboration Under 100 Million Dollar Grant To Target H5N1 Bird Flu

Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, announced it has initiated a research c...

February 24, 2026 | News

Singular Genomics Commercially Launches G4X to Scale Spatial Multiomics for Precision Medicine

Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, announced the commercial launch...

February 24, 2026 | News

AVEO Oncology Selects Ficlatuzumab Dose for Phase 3 FIERCE-HN Trial in Head and Neck Cancer

– Global enrollment continues in the Phase 3 registrational studyfollowing the planned first interim analysis for patients with HPV-negati...

February 24, 2026 | News

Hansa Biopharma Announces FDA Acceptance of Imlifidase Biologics License Application

Hansa Biopharma AB, ("Hansa" or "the Company"), announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S. F...

February 24, 2026 | News

Lunai Bioworks Secures Foundational U.S. Patent to Advance AI-Driven Precision Medicine

Foundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene Mapping Lunai Bioworks, Inc. (NASDAQ: ...

February 24, 2026 | News

Catalent And S Biomedics Partner To Advance Stem Cell Therapy For Parkinsons Disease

Catalent and S.Biomedics announced a strategic partnership to support the development and manufacturing of TED‑A9, S.Biomedics’ allogeneic pluripot...

February 23, 2026 | News

Asahi Kasei Pharma Advances AK1960 Into Phase I For Refractory Kidney Diseases

Asahi Kasei Pharma, a global provider of healthcare and pharmaceutical solutions, in collaboration with Alchemedicine, has announced that its novel Endothe...

February 23, 2026 | News

ANKTIVA Plus BCG Secures European Commission Authorization As First Immunotherapy For BCG Unresponsive NMIBC

ANKTIVA plus BCG, with a 71% complete response rate, is the first immunotherapy to receive marketing authorization in Europe for non-muscle invasive blad...

February 20, 2026 | News

Mammotome Introduces In Room MRI Guided Breast Biopsy System To Improve Clinical Workflow

Mammotome, a Danaher company, announces the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed t...

February 19, 2026 | News

Pharmacelera Secures €6 Million To Expand US Footprint And Advance Quantum AI Drug Discovery Platform

Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoi...

February 19, 2026 | News

Stay Connected